DR. RAHUL GUPTA

Employment

Employment history is unavailable.

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (15)

• Girdin silencing enhances mebendazole-mediated anticancer activity: a combinatorial therapeutic strategy for ovarian cancer
  Medical Oncology 2025 DOI: 10.1007/s12032-025-03210-5
  +Save
• Dual Targeting of Mitochondrial Membrane Potential and XIAP by Mebendazole Triggers Apoptosis in Ovarian Cancer Cells: An Integrated In Vitro and In Silico Perspective
  DNA and Cell Biology Reports 2025 DOI: 10.1177/29979811251379351
  +Save
• Suppression of endometriosis by miRNA-34a via inhibition of matrix metalloproteinase-2: An alternative pathway to impede invasion
  Non-coding RNA Research 2025 DOI: 10.1016/j.ncrna.2025.02.001
  +Save
• Mebendazole Exerts Anticancer Activity in Ovarian Cancer Cell Lines via Novel Girdin-Mediated AKT/IKKα/β/NF-κB Signaling Axis
  Cells 2025 DOI: 10.3390/cells14020113
  +Save
• Marine Natural Products
  2024 DOI: 10.4018/979-8-3693-5878-8.ch002
  +Save
• A mechanistic study on the tolerance of PAM distal end mismatch by SpCas9
  Journal of Biological Chemistry 2024 DOI: 10.1016/j.jbc.2024.107439
  +Save
• Marine natural products: A promising frontier in drug discovery
  Marine Metabolites in Disease Management 2024 DOI: 10.4018/979-8-3693-5878-8.ch002
  +Save
• A mechanistic study on the tolerance of PAM distal end mismatch by SpCas9
  Biorxiv 2023 DOI: 10.1101/2023.10.16.562469
  +Save
• An insight into SARS-CoV-2 structure, pathogenesis, target hunting for drug development and vaccine initiatives
  RSC Medicinal Chemistry 2022 DOI: 10.1039/d2md00009a
  +Save
• Cas13d: A New Molecular Scissor for Transcriptome Engineering
  Frontiers in Cell and Developmental Biology 2022 DOI: 10.3389/fcell.2022.866800
  +Save